Chugai Pharmaceutical
Clinical trials sponsored by Chugai Pharmaceutical, explained in plain language.
Chugai Pharmaceutical
4519
TOKYO
A Japanese pharmaceutical company focused on biotech and oncology drugs.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug targets immune overdrive in six rare diseases Results expected Mar 2027 (estimated)
- New hope for celiac sufferers: drug targets gut damage despite strict diet Results expected Jun 2027 (estimated)